Related Experiment Video

Updated: Jan 6, 2026

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

5.4K

Next-generation oncology: integrative therapeutic frontiers at the crossroads of precision genomics,

Ahmad M Alamri1, Abdullah A Assiri2, Bushra Khan3

  • 1Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, 61413, Abha, Saudi Arabia.

Medical Oncology (Northwood, London, England)
|September 20, 2025
PubMed

Insights

Cancer treatment is shifting towards an intelligence-driven approach, integrating precision genomics, immuno-engineering, and tumor microenvironment (TME) modulation. This systems-based strategy aims to overcome resistance and personalize therapies for better outcomes.

Area of Science:

  • Oncology
  • Systems Biology
  • Computational Biology

Background:

  • Cancer treatment is evolving from cytotoxic therapies to an integrative, intelligence-driven framework.
  • Cancer is viewed as a complex adaptive system (CAS) driven by genetic, epigenetic, and microenvironmental interactions.
  • Traditional mono-targeted therapies face limitations, necessitating synergistic and dynamic treatment strategies.

Purpose of the Study:

  • To review the paradigm shift in oncology towards precision genomics, immuno-engineering, and tumor microenvironment (TME) modulation.
  • To explore how cancer's complex adaptive system (CAS) nature requires multi-dimensional therapeutic approaches.
  • To highlight emerging synergistic strategies and technological advancements in cancer treatment.

Main Methods:

  • Review of current literature on advanced oncology frameworks, including precision genomics, immuno-engineering, and TME modulation.
  • Analysis of synergistic therapeutic approaches such as AI-guided dosing, synthetic biology, and metabolic reprogramming.
  • Exploration of breakthroughs in molecular cartography, quantum biology, synthetic oncology, and dark genome mining.

Main Results:

  • Emergence of synergistic approaches like AI-guided adaptive dosing, synthetic biology-enhanced CAR-T cells, and TME metabolic reprogramming.
  • Advancements in immuno-engineering (e.g., next-gen checkpoint modulators, neoantigen vaccines) and TME-targeted strategies (e.g., stromal remodeling, microbiome engineering).
  • Integration of multi-omics, combinatorial therapeutics, and computational oncology (e.g., digital twins) enables personalized interventions.

Conclusions:

  • A unified, systems-based approach is crucial for transforming cancer into a manageable condition.
  • Future oncology will be adaptive and autonomous, integrating AI, closed-loop therapies, and mRNA platforms for scaled precision medicine.
  • Addressing challenges like therapeutic resistance, toxicity, accessibility, and ethical concerns requires interdisciplinary collaboration.
Keywords:
Computational OncologyImmuno-EngineeringPrecision GenomicsSynthetic OncologyTumor Microenvironment (TME)

More Related Videos

Predictive Immune Modeling of Solid Tumors08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.4K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K